Skip navigation Scroll to top
Scroll to top


Muso works to tackle maternal and child mortality in sub-Saharan Africa through an innovative proactive care model.


Investee Muso, founded 2005
Location USA, Mali, Côte D'Ivoire
Sector Healthcare
Funding start October 2021
Funding type Grant




In 2017, every day approximately 810 women died globally from preventable causes related to pregnancy and childbirth. 94% of these deaths took place in low and lower middle-income countries. In 2019, an estimated 5.2 million children under the age of five died globally, mostly from preventable and treatable causes.

While health delivery is complex and challenges differ from country to country, in sub-Saharan Africa (SSA) these preventable deaths are mainly due to i) the poor quality of care and sub-standard clinical facilities, ii) income and demographic barriers to care (e.g., costs of facilities, distance, females lacking decision-making power), and iii) existing community health care systems failing to reach patients within the critical 24-hour window after symptom onset.


Founded in 2005, Muso is a non-profit organization active in Mali and Côte D'Ivoire (CDI) addressing maternal and child mortality in marginalized communities by providing timely access to health care. Muso works with government partners to develop Proactive Care, a model focused on ultra-rapid delivery of health care, led by Community Health Workers (CHWs). Proactive Care is based on the simple premise that early access to health care can avert nearly all maternal and under-five child deaths.

Muso has outlined three core offerings to address what they call “the challenge of delayed care”:

  1. Direct service delivery: Muso trains, supervises and supports CHWs to identify patients through door-to-door visits, provide them with essential doorstep care and facilitate referrals to reinforced primary health centers without fees.
  2. Technical assistance: In addition to providing direct care at the community level, Muso also provides technical assistance to Ministries of Health as they scale national CHW programs.
  3. Global Advocacy: Muso conducts extensive research on community health care and proactively shares insights with key global health care stakeholders in order to transform global health care policies and practices. Muso completed one of the world’s largest RCT trials on CHWs aiming to codify the impact of Proactive Care.

Impact depth

Thus far, Muso has provided 350’000 patients with better access to health care across 10 sites and has grown its team to over 500 staff. A 2018 study in BMJ Global Health found that the communities Muso serves in Mali, which previously had some of the world's highest child death rates, have now achieved a child death rate of seven per 1000, the lowest documented in sub-Saharan Africa.

By 2023, Muso aims to serve 700’000+ patients directly and reach a further four million people through technical assistance provided to governments. Muso is currently active in Mali and CDI and plans to expand to additional countries by 2023. Niger, Morocco and Sudan have approached Muso for support.

Muso has contributed to the global goal of reducing the under-five mortality rate to 25 per 1’000 live births and the maternal mortality rate to fewer than 70 per 100’000 live births by 2030 (SDG Targets 3.2 and 3.1, respectively).

Indicator 2021
# of sick patient evaluations 34'472 
# of CHWs trained, salaried and equipped 424
# of upgraded clinics 1




By investing in Muso, we align with and contribute to Goal 3 (Good Health and Well-Being) of the United Nations’ Sustainable Development Goals.